1. Home
  2. DMAC vs MVBF Comparison

DMAC vs MVBF Comparison

Compare DMAC & MVBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DMAC
  • MVBF
  • Stock Information
  • Founded
  • DMAC 2000
  • MVBF 1997
  • Country
  • DMAC United States
  • MVBF United States
  • Employees
  • DMAC N/A
  • MVBF N/A
  • Industry
  • DMAC Biotechnology: Pharmaceutical Preparations
  • MVBF Major Banks
  • Sector
  • DMAC Health Care
  • MVBF Finance
  • Exchange
  • DMAC Nasdaq
  • MVBF Nasdaq
  • Market Cap
  • DMAC 267.7M
  • MVBF 253.0M
  • IPO Year
  • DMAC N/A
  • MVBF N/A
  • Fundamental
  • Price
  • DMAC $6.51
  • MVBF $19.01
  • Analyst Decision
  • DMAC Strong Buy
  • MVBF Buy
  • Analyst Count
  • DMAC 3
  • MVBF 2
  • Target Price
  • DMAC $7.00
  • MVBF $27.50
  • AVG Volume (30 Days)
  • DMAC 81.8K
  • MVBF 29.4K
  • Earning Date
  • DMAC 03-18-2025
  • MVBF 02-13-2025
  • Dividend Yield
  • DMAC N/A
  • MVBF 3.58%
  • EPS Growth
  • DMAC N/A
  • MVBF N/A
  • EPS
  • DMAC N/A
  • MVBF 1.53
  • Revenue
  • DMAC N/A
  • MVBF $148,570,000.00
  • Revenue This Year
  • DMAC N/A
  • MVBF N/A
  • Revenue Next Year
  • DMAC N/A
  • MVBF $13.30
  • P/E Ratio
  • DMAC N/A
  • MVBF $12.42
  • Revenue Growth
  • DMAC N/A
  • MVBF 2.60
  • 52 Week Low
  • DMAC $2.14
  • MVBF $17.51
  • 52 Week High
  • DMAC $6.82
  • MVBF $25.24
  • Technical
  • Relative Strength Index (RSI)
  • DMAC 62.22
  • MVBF 39.51
  • Support Level
  • DMAC $5.75
  • MVBF $18.58
  • Resistance Level
  • DMAC $6.82
  • MVBF $20.43
  • Average True Range (ATR)
  • DMAC 0.30
  • MVBF 0.60
  • MACD
  • DMAC 0.02
  • MVBF -0.07
  • Stochastic Oscillator
  • DMAC 74.48
  • MVBF 19.46

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides community banking, mortgage banking, insurance and wealth management services to individuals and corporate clients in the Mid-Atlantic region. The Bank offers its customers various products, such as checking accounts, negotiable order of withdrawal (NOW) accounts, money market and savings accounts, time certificates of deposit, commercial, installment, commercial real estate and residential real estate mortgage loans, debit cards, and safe deposit rental facilities. MVB has three reportable segments: CoRe banking; mortgage banking and the financial holding company. It generates majority of its revenues from its CoRe banking segment.

Share on Social Networks: